Importance of digital health in patient management of Parkinson's diseaseCHAN Piu, ZHANG Qi-hao127-130
Alarming signs and biomarkers of isolated rapid eye movement behavior disorder transforming into α-syncleinopathiesZHU Xue, LIU Jun131-136
Dynamic brain function analysis based on resting-state fMRI and its application in neurodegenerative diseasesTIAN Yuan, LI Kai, SU Wen137-141
Advances in research on the association between sleep disorders and cognitive dysfunction in Parkinson's diseaseZHOU Chuan-bin, YIN Lei, XU Zhong142-146
Effect of astragaloside Ⅳ on SK-N-SH cells damage induced by 1-methyl-4-phenylpyridine in Parkinson's diseaseHUANG Xiao-jing, HUANG Huai, XU Zheng-hu, HUANG Wan-gang, YANG Dong-feng, REN He-cheng155-162
The use of Ofactory Test of Parkinson's Disease(KinPamor)in evaluation of olfactory function in Parkinson's diseaseLI Ling, WANG Feng, LU Zhen-ze, ZHANG Li-fang163-167
Correlation between the time from rapid eye movement sleep behavior disorder to disease onset and clinical characteristics in Parkinson's diseaseLI Xin, REN Ning, WANG Min, CHEN Xue-jiao, CHEN Lei168-172
Study on related risk factors of pain in de novo Parkinson's disease patientsGUO Zhi-ying, LIU Wei-guo, SUN Yu, ZHENG Hui-fen, YANG Yu-xuan, ZHAO Ming-ming173-178
Risk factors screening of acute symptomatic seizure secondary to anti-N-methyl-D-aspartate receptor encephalitis based on Nomogram modelWANG Xue, LIU Xiao, LI Zhi-mei, WANG Qun179-186